Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 3.983
Filtrar
1.
Recurso de Internet en Portugués | LIS - Localizador de Información en Salud | ID: lis-47839

RESUMEN

Desde o início da pandemia, o Governo do Brasil, por meio do Ministério da Saúde, destinou aos 26 estados e o Distrito Federal R$ 83,6 bilhões. Desse total, R$ 58,1 bilhões foram para serviços de rotina do SUS, e os outros R$ 25,5 bilhões para o enfrentamento da Covid-19.


Asunto(s)
Infecciones por Coronavirus , Pandemias/prevención & control , Colaboración Intersectorial
4.
Plast Reconstr Surg ; 146(2): 437-446, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32740603

RESUMEN

The coronavirus disease 2019 (COVID-19) pandemic has confronted the U.S. health care system with unprecedented challenges amidst a tenuous economic environment. As inpatient hospitals across the country prepare for an overwhelming influx of highly contagious COVID-19 cases, many nonemergent procedures have been cancelled or indefinitely postponed without guidance regarding eventual safe accommodation of these procedures in the future. Given the potentially prolonged impact of the COVID-19 pandemic on health care use, it is imperative for plastic surgeons to collaborate with other medical and surgical specialties to develop surge capacity protocols that allow continuation of safe, high-quality, nonemergent procedures. The purpose of this article is to provide necessary and timely public health information relevant to plastic surgery and also share a conceptual framework to guide surge capacity protocols for nonemergent surgery.


Asunto(s)
Betacoronavirus/patogenicidad , Infecciones por Coronavirus/prevención & control , Pandemias/prevención & control , Neumonía Viral/prevención & control , Regionalización/organización & administración , Capacidad de Reacción/organización & administración , Cirugía Plástica/organización & administración , Procedimientos Quirúrgicos Ambulatorios/normas , Betacoronavirus/aislamiento & purificación , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/terapia , Infecciones por Coronavirus/transmisión , Procedimientos Quirúrgicos Electivos/normas , Humanos , Control de Infecciones/normas , Colaboración Intersectorial , Neumonía Viral/epidemiología , Neumonía Viral/terapia , Neumonía Viral/transmisión , Guías de Práctica Clínica como Asunto , Procedimientos Quirúrgicos Reconstructivos/normas , Regionalización/normas , Cirugía Plástica/normas , Centros Quirúrgicos/organización & administración , Centros Quirúrgicos/normas , Telemedicina/organización & administración , Telemedicina/normas , Estados Unidos
6.
Emergencias (Sant Vicenç dels Horts) ; 32(4): 269-277, ago. 2020. graf, tab
Artículo en Español | IBECS | ID: ibc-190943

RESUMEN

La investigación es una de las labores inalienables al ejercicio de la profesión médica. En el ámbito de la medicina de urgencias y emergencias (MUE), durante las últimas décadas se ha producido un aumento progresivo de esta actividad, liderada por los propios profesionales que trabajan en servicios de urgencias hospitalarios (SUH) y en los sistemas médicos de emergencias. No obstante, su producción científica se ha fundamentado más en la actividad de grupos unicéntricos que en redes de colaboración entre centros. Los últimos años, no obstante, han aparecido líneas de investigación exclusivamente dedicadas a la MUE en diversos institutos de investigación sanitaria españoles, reconocidos por el Instituto de Salud Carlos III, y también grupos de investigación de procesos específicos con una producción mantenida en el tiempo, muchos de ellos vinculados a la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES). En el contexto de la pandemia de COVID-19 generada por el SARS-CoV-2, ha surgido la necesidad de que estos elementos investigadores unan sus fuerzas para hacer frente a los principales retos investigadores que supone esta pandemia desde la perspectiva de los SUH. Ello ha conducido a la fundación de la red de investigación SIESTA (Spanish Investigators on Emergency Situacions TeAm), cuyo primer reto es la realización del macroproyecto UMC-19 (Unusual Manifestations of Covid-19) en el plazo de un mes. A continuación se describen los pasos seguidos y los principales hitos de esta experiencia primigenia


Research is an inalienable part of medicine. The last few decades have seen a steady increase in research relevant to emergency medicine, led by professionals working in hospital emergency departments and related medical services. Most of the work has been done by groups in individual rather than networked centers. However, several Spanish institutions recognized by the Carlos III Health Institute (ISCIII) have developed lines of research that focus exclusively on emergency medicine. In addition, stable research groups - many of them associated with the Spanish Society of Emergency Medicine (SEMES) - have been engaged in ongoing studies of processes specific to our field. The coronavirus disease 2019 (COVID-19) pandemic caused by the acute respiratory syndrome coronavirus 2 (SARSCoV-2) created a need to focus all our efforts on the main challenges facing emergency departments. In response, the SIESTA (Spanish Investigators in Emergency Situations TeAm) network was created. The network's first challenge has been to complete the UMC-19 (Unusual Manifestations of COVID-19) macroproject within a single month. This paper describes the steps SIESTA followed and the main goals of this pioneering experience


Asunto(s)
Humanos , Colaboración Intersectorial , Servicios Médicos de Urgencia/organización & administración , Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Servicios Médicos de Urgencia/ética , Servicios Médicos de Urgencia/métodos , Planes y Programas de Salud/organización & administración , Formulación de Proyectos , España/epidemiología
9.
Ann Biomed Eng ; 48(9): 2281-2284, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32710248

RESUMEN

The global COVID-19 pandemic disrupted supply chains across the world, resulting in a critical shortage of personal protective equipment (PPE) for frontline healthcare workers. To preserve PPE for healthcare providers treating COVID-19 positive patients and to reduce asymptomatic transmission, the Department of Bioengineering at the University of Colorado, Denver | Anschutz Medical Campus collaborated with National Jewish Health to design and test patterns for cloth face coverings. A public campaign to sew and donate the final pattern was launched and over 2500 face coverings have been donated as a result. Now that nearly three million cases of COVID-19 have been confirmed in the United States, many state and local governments are requiring cloth face coverings be worn in public. Here, we present the collaborative design and testing process, as well as the final pattern for non-patient facing hospital workers and community members alike.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/prevención & control , Máscaras/provisión & distribución , Pandemias/prevención & control , Equipo de Protección Personal/provisión & distribución , Neumonía Viral/prevención & control , Ingeniería Biomédica , Colorado/epidemiología , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Personal de Salud , Hospitales , Humanos , Colaboración Intersectorial , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Textiles , Estados Unidos/epidemiología , Diseño Universal
10.
J Gen Intern Med ; 35(9): 2732-2737, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32661930

RESUMEN

Hospitalists are well poised to serve in key leadership roles and in frontline care in particular when facing a pandemic such as the SARS-CoV-2 (COVID-19) infection. Much of the disaster planning in hospitals around the country addresses overcrowded emergency departments and decompressing these locations; however, in the case of COVID-19, intensive care units, emergency departments, and medical wards ran the risk of being overwhelmed by a large influx of patients needing high-level medical care. In a matter of days, our Division of Hospital Medicine, in partnership with our hospital, health system, and academic institution, was able to modify and deploy existing disaster plans to quickly care for an influx of medically complex patients. We describe a scaled approach to managing hospitalist clinical operations during the COVID-19 pandemic.


Asunto(s)
Betacoronavirus , Creación de Capacidad/métodos , Infecciones por Coronavirus/prevención & control , Planificación en Desastres/métodos , Médicos Hospitalarios , Hospitales , Pandemias/prevención & control , Neumonía Viral/prevención & control , Creación de Capacidad/tendencias , Contención de Riesgos Biológicos/métodos , Contención de Riesgos Biológicos/tendencias , Infecciones por Coronavirus/epidemiología , Planificación en Desastres/tendencias , Médicos Hospitalarios/tendencias , Hospitales/tendencias , Humanos , Colaboración Intersectorial , Neumonía Viral/epidemiología
11.
PLoS One ; 15(7): e0234642, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32614845

RESUMEN

The role of external actors in national health policy in aid-independent countries has received relatively little attention in the literature, despite the fact that influence continues to be exerted once financial support is curtailed as countries graduate from lower income status. Focusing on a specific health policy in an aid-independent country, this qualitative study explores the role of external actors in shaping Thailand's migrant health insurance. Primary data were collected through in-depth interviews with eighteen key informants from September 2018 to January 2019. The data were analysed using thematic analysis, focusing on three channels of influence, financial resources, technical expertise and inter-sectoral leverage, and their effect on the different stages of the policy process. Given Thailand's export orientation and the importance of reputational effects, inter-sectoral leverage, mainly through the US TIP Reports and the EU carding decision, emerged as a very powerful channel of influence on priority setting, as it indirectly affected the migrant health insurance through efforts aimed at dealing with problems of human trafficking in the context of labour migration, especially after the 2014 coup d'état. This study helps understand the changed role external actors can play in filling health system gaps in aid-independent countries.


Asunto(s)
Política de Salud , Pacientes no Asegurados , Determinantes Sociales de la Salud , Migrantes , Cobertura Universal del Seguro de Salud , Financiación del Capital , Organizaciones de Beneficencia/economía , Países en Desarrollo , Agencias Gubernamentales , Gastos en Salud , Trata de Personas , Humanos , Agencias Internacionales , Colaboración Intersectorial , Entrevistas como Asunto , Pacientes no Asegurados/legislación & jurisprudencia , Organizaciones/economía , Política , Cambio Social , Tailandia , Migrantes/legislación & jurisprudencia , Inmigrantes Indocumentados/legislación & jurisprudencia , Cobertura Universal del Seguro de Salud/economía , Cobertura Universal del Seguro de Salud/legislación & jurisprudencia , Cobertura Universal del Seguro de Salud/estadística & datos numéricos
12.
Am J Public Health ; 110(S2): S232-S234, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32663092

RESUMEN

Objectives. To examine the extent to which social service organizations participate in the organizational networks that implement public health activities in US communities, consistent with recent national recommendations.Methods. Using data from a national sample of US communities, we measured the breadth and depth of engagement in public health activities among specific types of social and community service organizations.Results. Engagement was most prevalent (breadth) among organizations providing housing and food assistance, with engagement present in more than 70% of communities. Engagement was least prevalent among economic development, environmental protection, and law and justice organizations (less than 33% of communities). Depth of engagement was shallow and focused on a narrow range of public health activities.Conclusions. Cross-sector relationships between public health and the housing and food sectors are now widespread across the United States, giving most communities viable avenues for addressing selected social determinants of health. Relationships with many other social and community service organizations are more limited.Public Health Implications. Public health leaders should prioritize opportunities for engagement with low-connectivity social sectors in their communities such as law, justice, and economic development.


Asunto(s)
Colaboración Intersectorial , Administración en Salud Pública/estadística & datos numéricos , Servicio Social/estadística & datos numéricos , Conducta Cooperativa , Humanos , Salud Pública , Bienestar Social/estadística & datos numéricos , Estados Unidos
14.
Urologe A ; 59(8): 912-918, 2020 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-32638067

RESUMEN

The request for increased outpatient care is currently widely discussed in healthcare debates. With that, the sectoral interface (outpatient/hospital) is receiving greater attention, which provides an incentive for better cooperation and coordination of all healthcare providers. This also marks an opportunity to establish new cross-sectoral structures-also for research. The definitions of cross-sectoral care and the research content need to be in a standardized and consolidated manner. The provision of treatment data along the entire patent's path remains essential for health services research. In this context, the cross-sectoral interface could be regarded as fragile in that it is particularly sensitive to disruptions. The current increasing digitalization can also be seen as an opportunity to minimize the loss of information through the further development of cross-sectoral structures and to improve patient care, while simultaneously making a contribution to research across sectoral borders.


Asunto(s)
Prestación de Atención de Salud , Investigación sobre Servicios de Salud , Colaboración Intersectorial , Atención Ambulatoria , Humanos
15.
Urologe A ; 59(8): 931-940, 2020 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-32691108

RESUMEN

BACKGROUND: The aim of the study is to compare the German specialization training in urology with other European concepts, to analyze regional differences and to evaluate the development of the personnel structure in urology in German hospitals and private practices for the last 5 years. In addition, possibilities for financial funding of residents in the outpatient sector will be analyzed. MATERIALS AND METHODS: After analyzing the changes in the new Urology Specialization Training Regulations (Musterweiterbildungsordnung), the current urology training situation in Germany was evaluated in a European comparison. A trend analysis of the personnel structure in urology has been performed for recent years. Additionally, a possible intersectoral rotation concept was developed. Financial funding possibilities for urological residents were evaluated in a standardized telephone survey. RESULTS: Compared to other European countries, the exceptional position of German urology with its enormous spectrum becomes evident. In some states, there are already possibilities of financial support provided by regional Associations of Statutory Health Insurance Physicians (Krankenversicherung) for the training of urological residents in private practices. CONCLUSIONS: While the organization of specialization training is commonly nation based in other European countries, there is heterogeneity in Germany due to the sovereignty of the states. Due to the shift of many specialization training contents towards the outpatient sector, alliances between clinics and practices in the sense of intersectoral training will become more important in the future. Therefore, the use of already existing funds and-as a long-term objective-a nationwide access to such funding is desirable.


Asunto(s)
Internado y Residencia , Colaboración Intersectorial , Urología/educación , Curriculum , Europa (Continente) , Alemania , Humanos , Especialización
16.
Infect Dis Poverty ; 9(1): 86, 2020 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-32646512

RESUMEN

Emerging and re-emerging zoonotic diseases represent a public health challenge of international concern. They include a large group of neglected tropical diseases (NTDs), many of which are of zoonotic nature. Coronavirus disease 2019 (COVID-19), another emerging zoonotic disease, has just increased the stakes exponentially. Most NTDs are subject to the impact of some of the very same human-related activities triggering other emerging and re-emerging diseases, including COVID-19, severe acute respiratory syndrome (SARS), bird flu and swine flu. It is conceivable that COVID-19 will exacerbate the NTDs, as it will divert much needed financial and human resources. There is considerable concern that recent progress achieved with control and elimination efforts will be reverted. Future potential strategies will need to reconsider the determinants of health in NTDs in order to galvanize efforts and come up with a comprehensive, well defined programme that will set the stage for an effective multi-sectorial approach. In this Commentary, we propose areas of potential synergies between the COVID-19 pandemic control efforts, other health and non-health sector initiatives and NTD control and elimination programmes.


Asunto(s)
Enfermedades Transmisibles Emergentes/prevención & control , Infecciones por Coronavirus/epidemiología , Enfermedades Desatendidas/prevención & control , Neumonía Viral/epidemiología , Medicina Tropical/métodos , Animales , Betacoronavirus , Enfermedades Transmisibles Emergentes/epidemiología , Infecciones por Coronavirus/prevención & control , Salud Global , Humanos , Colaboración Intersectorial , Enfermedades Desatendidas/epidemiología , Pandemias/prevención & control , Neumonía Viral/prevención & control , Asignación de Recursos , Medicina Tropical/tendencias , Zoonosis/epidemiología , Zoonosis/prevención & control
18.
Ann Biol Clin (Paris) ; 78(3): 269-277, 2020 Jun 01.
Artículo en Inglés | MEDLINE | ID: covidwho-600996

RESUMEN

The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14th, the start of the planned containment exit from May 11th. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.


Asunto(s)
Betacoronavirus , Bioquímica/organización & administración , Biomarcadores/análisis , Servicios de Laboratorio Clínico/organización & administración , Infecciones por Coronavirus/diagnóstico , Neumonía Viral/diagnóstico , Sociedades Científicas/organización & administración , Betacoronavirus/aislamiento & purificación , Betacoronavirus/patogenicidad , Bioquímica/normas , Biomarcadores/sangre , Servicios de Laboratorio Clínico/normas , Redes Comunitarias/organización & administración , Redes Comunitarias/normas , Redes Comunitarias/tendencias , Infecciones por Coronavirus/sangre , Infecciones por Coronavirus/epidemiología , Brotes de Enfermedades , Francia/epidemiología , Historia del Siglo XXI , Humanos , Colaboración Intersectorial , Pandemias , Neumonía Viral/sangre , Neumonía Viral/epidemiología , Práctica Profesional/organización & administración , Práctica Profesional/normas , Práctica Profesional/tendencias , Sociedades Científicas/normas , Comunicación por Videocoferencia/organización & administración , Comunicación por Videocoferencia/normas
19.
Ann Biol Clin (Paris) ; 78(3): 269-277, 2020 Jun 01.
Artículo en Inglés | MEDLINE | ID: covidwho-600995

RESUMEN

The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14th, the start of the planned containment exit from May 11th. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.


Asunto(s)
Betacoronavirus , Bioquímica/organización & administración , Biomarcadores/análisis , Servicios de Laboratorio Clínico/organización & administración , Infecciones por Coronavirus/diagnóstico , Neumonía Viral/diagnóstico , Sociedades Científicas/organización & administración , Betacoronavirus/aislamiento & purificación , Betacoronavirus/patogenicidad , Bioquímica/normas , Biomarcadores/sangre , Servicios de Laboratorio Clínico/normas , Redes Comunitarias/organización & administración , Redes Comunitarias/normas , Redes Comunitarias/tendencias , Infecciones por Coronavirus/sangre , Infecciones por Coronavirus/epidemiología , Brotes de Enfermedades , Francia/epidemiología , Historia del Siglo XXI , Humanos , Colaboración Intersectorial , Pandemias , Neumonía Viral/sangre , Neumonía Viral/epidemiología , Práctica Profesional/organización & administración , Práctica Profesional/normas , Práctica Profesional/tendencias , Sociedades Científicas/normas , Comunicación por Videocoferencia/organización & administración , Comunicación por Videocoferencia/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA